Cationic cyclometalated platinum (II) complexes of metformin with self-assembly and AIE behavior as nuclear and mitochondrial targeted anticancer theragnostic agents
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Luminescence and Fluorescent Materials · Organic Light-Emitting Diodes Research · Click Chemistry and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (61)
Show source-provided references
1. Nanocarriers for delivery of platinum anticancer drugs10.1016/j.addr.2013.09.014 ↗
2. Functionalization of platinum complexes for biomedical applications10.1021/acs.accounts.5b00203 ↗
3. Platinum(IV) antitumor complexes and their nano-drug delivery10.1016/j.ccr.2020.213640 ↗
4. Advances in toxicological research of the anticancer drug cisplatin10.1021/acs.chemrestox.9b00204 ↗
5. The rediscovery of platinum-based cancer therapy10.1038/s41568-020-00308-y ↗
6. Classical vs. Non-classical cyclometalated Pt(II) complexes10.3390/molecules27217249 ↗
7. Cellular imaging properties of phosphorescent iridium(iii) complexes substituted with ester or amide groups10.1039/D2DT01551J ↗
8. Phosphorescent Pt(II) and Pd(II) complexes for efficient, high-color-quality, and stable OLEDs10.1002/adma.201601861 ↗
9. Highly phosphorescent cyclometalated platinum (II) complexes based on 2-phenylbenzimidazole-containing ligands10.1039/C7TC01369H ↗
10. The triple-stimuli-responsive luminescence switching properties and application of a square-planar platinum (II) complex10.1016/j.dyepig.2022.110139 ↗
11. Luminescent d8 metal complexes of platinum (II) and gold (III): from photophysics to photofunctional materials and probes10.1016/j.ccr.2020.213298 ↗
12. Ligand-controlled and nanoconfinement-boosted luminescence employing Pt(ii) and Pd(ii) complexes: from color-tunable aggregation-enhanced dual emitters towards self-referenced oxygen reporters10.1039/D0SC06126C ↗
13. Highly phosphorescent platinum (II) emitters: photophysics, materials and biological applications10.1039/C5SC03766B ↗
14. Toward the design and construction of supramolecular functional molecular materials based on metal–metal interactions10.1021/jacs.2c08551 ↗
15. Asymmetric tris-heteroleptic cyclometalated phosphorescent iridium(III) complexes: an emerging class of metallophosphors10.1021/accountsmr.2c00078 ↗
16. Aggregate science: from structures to properties
17. Photoactivatable biomedical materials based on luminogens with aggregation-induced emission (AIE) characteristics10.1002/adhm.202101177 ↗
18. Aggregation-induced emission (AIE) fluorophores as imaging tools to trace the biological fate of nano-based drug delivery systems10.1016/j.addr.2018.12.004 ↗
19. Aggregation‐induced emission (AIE): a historical perspective10.1002/anie.202007525 ↗
20. Aggregation-induced emission of 1-methyl-1, 2, 3, 4, 5-pentaphenylsilole10.1039/b105159h ↗
21. Supramolecular assembly of organoplatinum (II) complexes for subcellular distribution and cell viability monitoring with differentiated imaging
22. Polymer-induced self-assembly of alkynylplatinum (II) terpyridyl complexes by Metal⋅⋅⋅Metal/π⋅⋅⋅π10.1002/anie.200461261 ↗
23. Intracellular dynamic assembly of deep-red emitting supramolecular nanostructures based on the Pt…Pt metallophilic interaction10.1002/adma.202008613 ↗
24. Aggregation-induced phosphorescence emission (AIPE) behaviors in PtII(C^N)(N-donor ligand)Cl-type complexes through restrained D2d deformation of the coordinating skeleton and their optoelectronic properties10.1039/D0TC05527A ↗
25. Single bond activated AIE of platinum (II) complex achieving expeditious oxygen monitoring and high-efficiency felodipine identification10.1016/j.dyepig.2022.110582 ↗
26. Evolution of aromatic structures during the low-temperature electrochemical upgrading of bio-oil10.1021/acs.energyfuels.9b03099 ↗
27. Mechanochromic luminescent property and anti-counterfeiting application of AIE-active cyclometalated platinum (II) complexes featuring a fused five-six-membered metallacycle10.1016/j.dyepig.2021.109857 ↗
28. AIE-active Ir (III) complexes functionalised with a cationic Schiff base ligand: synthesis, photophysical properties and applications in photodynamic therapy10.1039/D2DT02960J ↗
29. Aggregation-induced emission (AIE), Life and health10.1021/acsnano.3c03925 ↗
30. Deep red emissive carbonized polymer dots with unprecedented narrow full width at half maximum
31. Host and dopant materials for idealized deep-red organic electrophosphorescence devices10.1002/adma.201100610 ↗
32. Deep-red emitting Ir (III) complexes as type-I photosensitizers for lipid droplets targeted photodynamic therapy10.1002/asia.202300175 ↗
33. Type I photosensitizers based on phosphindole oxide for photodynamic therapy: apoptosis and autophagy induced by endoplasmic reticulum stress10.1039/D0SC00785D ↗
34. Introduction of a triphenylamine substituent on pyridyl rings as a springboard for a new appealing brightly luminescent 1,3-di-(2-pyridyl)benzene platinum(Ⅱ) complex family10.1039/D2DT01792J ↗
35. Energy efficient microwave-assisted preparation of deep red/near-infrared emitting lithium aluminate and gallate phosphors10.1016/j.jlumin.2021.118168 ↗
36. Metformin: an antihyperglycemic agent for treatment of type II diabetes10.1177/106002809603000210 ↗
37. Emerging trends in metformin prescribing in the United States from 2000 to 201510.1007/s40261-019-00799-0 ↗
38. Review of metformin use for type 2 diabetes prevention10.1016/j.amepre.2018.04.038 ↗
39. Sodium–glucose cotransporter inhibition: therapeutic potential for the treatment of type 2 diabetes mellitus10.1002/dmrr.2403 ↗
40. The cell-autonomous mechanisms underlying the activity of metformin as an anticancer drug10.1038/bjc.2016.385 ↗
41. Role of mitochondria in the mechanism(s) of action of metformin10.3389/fendo.2019.00294 ↗
42. Mitochondria as an important target of metformin: the mechanism of action, toxic and side effects, and new therapeutic applications10.1016/j.phrs.2022.106114 ↗
43. Oncogenic pathways and the electron transport chain: a dangeROS liaison10.1038/s41416-019-0651-y ↗
44. Medicine, HIF-1α stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells10.1016/j.freeradbiomed.2011.05.042 ↗
45. Cardiolipin-targeted peptides rejuvenate mitochondrial function, remodel mitochondria, and promote tissue regeneration during aging10.1016/j.abb.2018.10.013 ↗
46. Metformin potentiates the anticancer effects of cisplatin under normoxic conditions in vitro10.3892/or.2014.3611 ↗
47. Combination of bis (α-furancarboxylato) oxovanadium (IV) and metformin improves hepatic steatosis through down-regulating inflammatory pathways in high-fat diet-induced obese C57BL/6J mice10.1111/bcpt.13573 ↗
48. Combination of aloin and metformin enhances the antitumor effect by inhibiting the growth and invasion and inducing apoptosis and autophagy in hepatocellular carcinoma through PI3K/AKT/mTOR pathway10.1002/cam4.2723 ↗
49. Combined regimens of cisplatin and metformin in cancer therapy: a systematic review and meta-analysis10.1016/j.lfs.2022.120680 ↗
50. Effect of metformin and Vernonia amygdalina leaf extract loaded PEGylatedmucin formulation on haematological, kidney and liver indices of healthy and Diabetes rats
51. Near-infrared phosphorescent cyclometalated platinum (II) and iridium (III) complexes with metformin moiety: design and study towards anticancer theranostic agents10.1016/j.jinorgbio.2022.111992 ↗
52. The saturated red electrophosphorescence based on phenylquinoline iridium complexes with fluorenyl unit10.1016/j.optmat.2022.112870 ↗
53. Sprouse · J Am Chem Soc · 1984 · 106 · 664710.1021/ja00334a031 ↗
54. Synthesis, luminescence quantum yields, and lifetimes of trischelated ruthenium(II) mixed-ligand complexes including 3,3′-Dimethyl-2,2′-bipyridyl10.1246/bcsj.55.2697 ↗
55. Mechanism of cellular uptake of a ruthenium polypyridyl complex10.1021/bi800856t ↗
56. Multistimuli responsive solid-state emission of a zinc(II) complex with multicolour switching10.1021/acs.inorgchem.1c01586 ↗
57. Iridium(iii) complexes with five-membered heterocyclic ligands for combined photodynamic therapy and photoactivated chemotherapy10.1039/C7DT02477K ↗
58. Recent advances in regenerative medicine strategies for cancer treatment10.1016/j.biopha.2021.111875 ↗
59. The saturated red electrophosphorescence based on phenylquinoline iridium complexes with fluorenyl unit10.1016/j.optmat.2022.112870 ↗
60. Mitochondrial membrane permeabilization in cell death10.1152/physrev.00013.2006 ↗
61. Zinc(ii) complexes containing bis-benzimidazole derivatives as a new class of apoptosis inducers that trigger DNA damage-mediated p53 phosphorylation in cancer cells10.1039/c3dt33077j ↗